CorMedix CRMD
NASDAQ CRMD
$7.79 +0.22 (+2.91%)
At close: Oct 21, 2026 · 4:00 PM EDT

CorMedix (CRMD) Receivables - Other (2010 - 2024)

Updated

CorMedix's Receivables - Other came in at $500,000 for Q2 2024.

Analysis

CorMedix (CRMD) Receivables - Other (2010 - 2024) Analysis & Trends

At the end of FY2011, CorMedix's Receivables - Other was $493,855, up 75.8% from FY2010.

  • Going back by year, Receivables - Other was $280,920 in FY2010.
  • The Q2 2024 figure represents the lowest quarterly Receivables - Other since Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 CorMedix 609.51 Mn -43.01 Mn 77.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 500,000.00
Dec 31, 2011 493,855.00
Dec 31, 2010 280,920.00
API Access

CorMedix Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=CRMD&period=max&api_key=YOUR_API_KEY